There is no way to foreshadow a successful outcome of a clinical research trial; however, utilizing FDA guidance and recognizing common causes of an “off-track” study may help with early identification and correction of any necessary study clean-up.
IMARC Research’s newest whitepaper details seven common causes of a non-compliant study, along with five suggestions for getting your study back on track.
Please take time to download our whitepaper and share your thoughts on how you have helped to get your study back on track.
